MARATTO

article · Journal of Genetic Engineering and Biotechnology

In silico prediction and structural profiling of human CYP2E1 missense variants implicated in hepatotoxic injuries

2026Open accessMohammed V University

Abstract

CYP2E1 sits at the crossroads of xenobiotic metabolism and oxidative-stress generation, yet the functional consequences of most coding variants are unknown. We developed a structure-aware in silico pipeline to prioritize and mechanistically profile human CYP2E1 nsSNPs. From 490 missense SNPs collected, a consensus cascade of 27 prediction tools and evolutionary conservation filters yielded 24 high-confidence candidates, six highly conserved substitutions were subjected to all-atom MD. Trajectories analysis revealed variant-specific atomistic phenotypes spanning core collapse, access-tunnel rigidification, and localized electrostatic destabilization. G300R produced the largest structural disruption, while R359P induced pronounced rigidification of access-region dynamics, both emerged as top candidates for altered coupling efficiency and hepatotoxic risk. We provided a ranked variant list and mechanistic hypotheses linking coding substitutions to altered heme positioning and potential increases in ROS leakage. This structure-based prioritization framework is intended to guide experimental biochemical, cellular and pharmacogenetic follow-up in studies of drug-induced and chronic liver injury.

Research topics

  • Pharmacogenetics and Drug Metabolism
  • Glutathione Transferases and Polymorphisms
  • Drug-Induced Hepatotoxicity and Protection

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.jgeb.2026.100799

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.